Title : Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells.

Pub. Date : 2008 Sep

PMID : 18381602






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A significant synergistic growth inhibitory effect was observed with the combination of bortezomib and each EGFR inhibitor in all cell lines (combination index, CI, range 0.10-0.55), which was accompanied by a significant induction in apoptosis by the combined treatment with bortezomib, cetuximab and vandetanib. vandetanib epidermal growth factor receptor Homo sapiens